• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Raysearch Laboratories

232.40 SEK

-0.34 %

Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.34 %
+7.29 %
+19.67 %
+5.88 %
+1.93 %
-30.52 %
+267.14 %
+164.69 %
+316.67 %

RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. RaySearch Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

Read more
Market cap
7.97B SEK
Turnover
8.9M SEK
Revenue
1.34B
EBIT %
21.74 %
P/E
34.95
Dividend yield-%
1.72 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.8
2026

Interim report Q2'26

3.11
2026

Interim report Q3'26

10.2
2027

Annual report '26

Press release03.07.2026, 09.23

Yonsei Cancer Center expands use of RayStation

Raysearch Laboratories
Press release01.07.2026, 14.34

RaySearch releases RayStation v2026

Raysearch Laboratories
Press release29.06.2026, 12.56

RayIntelligence v2026: Advancing oncology analytics

Raysearch Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release26.06.2026, 10.45

Utilization of authorization to acquire own shares

Raysearch Laboratories
Press release18.06.2026, 10.15

RaySearch enters the Vietnamese market

Raysearch Laboratories
Regulatory press release16.06.2026, 14.14

Utilization of authorization to acquire own shares

Raysearch Laboratories
Press release05.06.2026, 09.35

RaySearch to showcase new advances in particle therapy at PTCOG 64

Raysearch Laboratories
Press release21.05.2026, 13.38

Antony Lomax joins RaySearch to strengthen leadership in particle therapy

Raysearch Laboratories
Press release18.05.2026, 09.06

First patients treated with RayCare at Raigmore Hospital

Raysearch Laboratories
Press release13.05.2026, 17.30

RaySearch to showcase groundbreaking innovations at ESTRO 2026

Raysearch Laboratories
Press release12.05.2026, 10.05

First online adaptive treatment on TrueBeam using RayStation and RayCare

Raysearch Laboratories
Regulatory press release07.05.2026, 20.10

Bulletin from the Annual General Meeting 2026

Raysearch Laboratories
Regulatory press release29.04.2026, 07.30

Interim report first quarter 2026: Strong long-term performance and raised margin target

Raysearch Laboratories
Press release27.04.2026, 10.20

Institut Hartmann selects RayStation and RayCare

Raysearch Laboratories
Press release22.04.2026, 11.10

Invitation to presentation of RaySearch’s interim report for the first quarter of 2026

Raysearch Laboratories
Regulatory press release19.04.2026, 19.45

Günther Mårder resigns from the Board of RaySearch

Raysearch Laboratories
Press release17.04.2026, 08.45

RaySearch receives first RayCare order in China

Raysearch Laboratories
Regulatory press release15.04.2026, 16.15

RaySearch publishes Annual Report for 2025

Raysearch Laboratories
Regulatory press release02.04.2026, 10.00

Notice of Annual General Meeting 2026

Raysearch Laboratories
Press release19.03.2026, 10.05

First patient treated in Ukraine using RayStation

Raysearch Laboratories